Relationships between cognitive biases, decision-making, and delusions.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
10 06 2023
Historique:
received: 27 09 2022
accepted: 05 06 2023
medline: 12 6 2023
pubmed: 11 6 2023
entrez: 10 6 2023
Statut: epublish

Résumé

Multiple measures of decision-making under uncertainty (e.g. jumping to conclusions (JTC), bias against disconfirmatory evidence (BADE), win-switch behavior, random exploration) have been associated with delusional thinking in independent studies. Yet, it is unknown whether these variables explain shared or unique variance in delusional thinking, and whether these relationships are specific to paranoia or delusional ideation more broadly. Additionally, the underlying computational mechanisms require further investigation. To investigate these questions, task and self-report data were collected in 88 individuals (46 healthy controls, 42 schizophrenia-spectrum) and included measures of cognitive biases and behavior on probabilistic reversal learning and explore/exploit tasks. Of those, only win-switch rate significantly differed between groups. In regression, reversal learning performance, random exploration, and poor evidence integration during BADE showed significant, independent associations with paranoia. Only self-reported JTC was associated with delusional ideation, controlling for paranoia. Computational parameters increased the proportion of variance explained in paranoia. Overall, decision-making influenced by strong volatility and variability is specifically associated with paranoia, whereas self-reported hasty decision-making is specifically associated with other themes of delusional ideation. These aspects of decision-making under uncertainty may therefore represent distinct cognitive processes that, together, have the potential to worsen delusional thinking across the psychosis spectrum.

Identifiants

pubmed: 37301915
doi: 10.1038/s41598-023-36526-1
pii: 10.1038/s41598-023-36526-1
pmc: PMC10257713
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

9485

Subventions

Organisme : NIMH NIH HHS
ID : K23 MH126313
Pays : United States

Informations de copyright

© 2023. The Author(s).

Références

Cogn Neuropsychiatry. 2011 Sep;16(5):422-47
pubmed: 21480015
Schizophr Res. 2013 Mar;144(1-3):63-71
pubmed: 23332365
PLoS Comput Biol. 2022 Jul 25;18(7):e1010326
pubmed: 35877675
Schizophr Bull. 2015 Sep;41(5):1183-91
pubmed: 25616503
Schizophr Res. 2011 Apr;127(1-3):115-22
pubmed: 20810252
J Am Geriatr Soc. 2021 Jun;69(6):1429-1440
pubmed: 33948937
Elife. 2020 May 26;9:
pubmed: 32452769
Schizophr Bull. 2017 Mar 1;43(2):344-354
pubmed: 27169465
Nat Commun. 2017 Jan 31;8:14218
pubmed: 28139642
Res Dev Disabil. 2021 Feb;109:103852
pubmed: 33465590
Br J Psychiatry. 1986 Jul;149:51-6
pubmed: 3779313
Psychiatry Res. 2018 Mar;261:535-540
pubmed: 29407719
J Consult Clin Psychol. 2004 Aug;72(4):671-80
pubmed: 15301652
JAMA Psychiatry. 2021 Jul 1;78(7):714-725
pubmed: 33825827
BMC Psychiatry. 2013 May 06;13:127
pubmed: 23648193
J Neurosci. 2018 Oct 31;38(44):9471-9485
pubmed: 30185463
Personal Neurosci. 2018 Oct 18;1:e18
pubmed: 32435735
J Stat Softw. 2010;33(1):1-22
pubmed: 20808728
Schizophr Res. 2020 Aug;222:202-208
pubmed: 32507550
Psychiatry Res. 2010 Jul 30;178(2):284-9
pubmed: 20483170
J Behav Ther Exp Psychiatry. 2017 Sep;56:42-50
pubmed: 27568886
Conscious Cogn. 2020 Aug;83:102956
pubmed: 32502909
Psychiatry Res. 2019 Mar;273:443-449
pubmed: 30684790
Early Interv Psychiatry. 2014 Nov;8(4):340-7
pubmed: 23773323
Schizophr Bull. 2010 Jul;36(4):830-5
pubmed: 19176474
Sci Rep. 2022 Jun 20;12(1):10352
pubmed: 35725585
J Clin Exp Neuropsychol. 2006 May;28(4):605-17
pubmed: 16624787
Psychiatr Serv. 2007 Apr;58(4):449-51
pubmed: 17412842
Compr Psychiatry. 2004 Sep-Oct;45(5):317-24
pubmed: 15332193
J Exp Psychol Gen. 2014 Dec;143(6):2074-81
pubmed: 25347535
Front Hum Neurosci. 2014 Nov 19;8:825
pubmed: 25477800
Front Hum Neurosci. 2011 May 02;5:39
pubmed: 21629826
Psychol Psychother. 2020 Dec;93(4):690-704
pubmed: 31583824
BMC Psychiatry. 2020 Nov 23;20(1):554
pubmed: 33228583
Neuropsychopharmacology. 2022 Jun;47(7):1339-1349
pubmed: 35017672
Schizophr Res. 2022 Jul;245:23-41
pubmed: 33676820
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Clin Psychol Rev. 2011 Jun;31(4):684-96
pubmed: 21482326
Elife. 2017 Sep 15;6:
pubmed: 28914605
Psychol Med. 2021 Jan;51(2):244-253
pubmed: 31744588
Psychol Med. 2009 Jun;39(6):881-7
pubmed: 18845010
Schizophr Res. 2004 Jun 1;68(2-3):319-29
pubmed: 15099613
Psychiatry Res. 2018 Dec;270:180-186
pubmed: 30261407
PLoS One. 2014 Sep 05;9(9):e105825
pubmed: 25192357
Nat Hum Behav. 2021 Sep;5(9):1190-1202
pubmed: 34316049
Schizophr Bull. 2004;30(4):1005-22
pubmed: 15954204
Soc Psychiatry Psychiatr Epidemiol. 2014 Jul;49(7):1045-50
pubmed: 24297621
Brain. 2019 Jun 1;142(6):1797-1812
pubmed: 30895299
Biol Psychiatry Cogn Neurosci Neuroimaging. 2022 Nov;7(11):1149-1157
pubmed: 35430406
Biol Psychiatry. 2018 Nov 1;84(9):634-643
pubmed: 30007575
Front Psychiatry. 2013 May 30;4:47
pubmed: 23750138
Schizophr Bull. 2018 Oct 17;44(6):1245-1253
pubmed: 29294128
Schizophr Bull. 2016 May;42(3):652-65
pubmed: 26519952
Schizophr Res Cogn. 2016 Mar;3:33-38
pubmed: 27990352
Cogn Neuropsychiatry. 2021 Jul;26(4):231-241
pubmed: 34102951
J Behav Ther Exp Psychiatry. 2017 Sep;56:51-56
pubmed: 27527489
Clin Psychol Rev. 2007 May;27(4):425-57
pubmed: 17258852
Comput Psychiatr. 2020;4:18-39
pubmed: 33768158

Auteurs

Julia M Sheffield (JM)

Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, 1601 23rd Ave S, Nashville, TN, 37209, USA. Julia.sheffield@vumc.org.

Ryan Smith (R)

Laureate Institute for Brain Research, Tulsa, USA.

Praveen Suthaharan (P)

Department of Psychiatry, Yale University, New Haven, USA.

Pantelis Leptourgos (P)

Department of Psychiatry, Yale University, New Haven, USA.
University of Lille, Lille, France.

Philip R Corlett (PR)

Department of Psychiatry, Yale University, New Haven, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH